The company made an even more dramatic claim the following month, when it announced it had created three dire wolves. These ...
Thanks to genetic science, gene editing, and techniques like cloning, it’s now possible to move DNA through time, studying ...
Scientists from UC Davis Center for Surgical Bioengineering, the MIND Institute and UC Berkeley’s Murthy Lab are developing ...
A new gene-editing technique enables the correction of multiple genetic mutations simultaneously, transforming the prospects for millions living with complex inherited diseases, such as cystic ...
The company has made more than 50 deals for its proprietary technology as it looks forward to a potentially “transformative” ...
Hosted on MSN
Gene-edited pigs may soon enter the Canadian market, but questions about their impact remain
The Canadian government is currently considering approving the entry of gene-edited pigs into the food system. Subscribe to our newsletter for the latest sci-tech news updates. Using CRISPR ...
Picture CRISPR-Cas9, a gene editing technology, as a GPS-guided scalpel: gRNA directs the Cas9 enzyme, a protein that cuts ...
Advances in the gene-editing technology known as CRISPR-Cas9 over the past 15 years have yielded important new insights into the roles that specific genes play in many diseases. But to date this ...
Hosted on MSN
Gene technology changes: What you need to know
New Zealand's gene technology rules are being updated, removing regulatory hurdles that have been in place for 30 years. Also known as genetic engineering or genetic modification, genetic technologies ...
Lexeo Therapeutics is teaming up with Big Pharma Johnson & Johnson's unit Abiomed to tap its Impella heart pump technology in search of a potentially safer and more effective route for cardiac genetic ...
Pharmaceutical Technology on MSN
FDA increases manufacturing flexibility for cell and gene therapies
Clinical and commercial quality controls are eased as the FDA looks to expedite therapy approvals in areas of unmet need.
Neurogene Inc. (Nasdaq: NGNE), a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, today announced a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results